Novel drug-eluting stents in the treatment of de novo coronary lesions

Due to safety concerns in recent years, much effort has been devoted to improving the outcomes associated with drug-eluting stents (DESs). This review summarizes the current status of methodological and technical achievements reported in second-generation DES. Novel stents are described based on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Capodanno, Davide, Dipasqua, Fabio, Tamburino, Corrado
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049546/
https://www.ncbi.nlm.nih.gov/pubmed/21415924
http://dx.doi.org/10.2147/VHRM.S11444
_version_ 1782199236208623616
author Capodanno, Davide
Dipasqua, Fabio
Tamburino, Corrado
author_facet Capodanno, Davide
Dipasqua, Fabio
Tamburino, Corrado
author_sort Capodanno, Davide
collection PubMed
description Due to safety concerns in recent years, much effort has been devoted to improving the outcomes associated with drug-eluting stents (DESs). This review summarizes the current status of methodological and technical achievements reported in second-generation DES. Novel stents are described based on the component (the platform, the polymer, and the drug) that has undergone the most significant changes compared to earlier generation DES. An overview of the currently available evidence on the use of novel coronary devices in patients undergoing coronary revascularization is also reviewed.
format Text
id pubmed-3049546
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30495462011-03-17 Novel drug-eluting stents in the treatment of de novo coronary lesions Capodanno, Davide Dipasqua, Fabio Tamburino, Corrado Vasc Health Risk Manag Review Due to safety concerns in recent years, much effort has been devoted to improving the outcomes associated with drug-eluting stents (DESs). This review summarizes the current status of methodological and technical achievements reported in second-generation DES. Novel stents are described based on the component (the platform, the polymer, and the drug) that has undergone the most significant changes compared to earlier generation DES. An overview of the currently available evidence on the use of novel coronary devices in patients undergoing coronary revascularization is also reviewed. Dove Medical Press 2011 2011-02-25 /pmc/articles/PMC3049546/ /pubmed/21415924 http://dx.doi.org/10.2147/VHRM.S11444 Text en © 2011 Capodanno et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Capodanno, Davide
Dipasqua, Fabio
Tamburino, Corrado
Novel drug-eluting stents in the treatment of de novo coronary lesions
title Novel drug-eluting stents in the treatment of de novo coronary lesions
title_full Novel drug-eluting stents in the treatment of de novo coronary lesions
title_fullStr Novel drug-eluting stents in the treatment of de novo coronary lesions
title_full_unstemmed Novel drug-eluting stents in the treatment of de novo coronary lesions
title_short Novel drug-eluting stents in the treatment of de novo coronary lesions
title_sort novel drug-eluting stents in the treatment of de novo coronary lesions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049546/
https://www.ncbi.nlm.nih.gov/pubmed/21415924
http://dx.doi.org/10.2147/VHRM.S11444
work_keys_str_mv AT capodannodavide noveldrugelutingstentsinthetreatmentofdenovocoronarylesions
AT dipasquafabio noveldrugelutingstentsinthetreatmentofdenovocoronarylesions
AT tamburinocorrado noveldrugelutingstentsinthetreatmentofdenovocoronarylesions

Ejemplares similares